raloxifene hydrochloride has been researched along with Coronary Artery Disease in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (20.00) | 18.2507 |
2000's | 8 (80.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abramson, BL; Amewou-Atisso, M; Barrett-Connor, E; Collins, P; Dowsett, SA; Geiger, MJ; Grady, D; Kornitzer, M; Mosca, L; Paganini-Hill, A; Wenger, N | 1 |
Jneid, H; Shepard, DR; Thacker, HL | 1 |
Celermajer, DS; Griffiths, KA; Harmer, JA; Sader, MA; Skilton, MR | 1 |
Flevari, P; Koniavitou, K; Kremastinos, DT; Kroupis, C; Kyriakides, ZS; Sbarouni, E | 1 |
Pines, A | 1 |
Levo, Y; Pines, A | 1 |
Anthony, MS; Clarkson, TB; Jerome, CP | 1 |
Bryant, HU; Cox, DA; Heath, H; Iversen, P; Kauffman, RF; Mitlak, BH | 1 |
Clarkson, TB; Mikkola, TS | 1 |
Gambacciani, M; Genazzani, AR | 1 |
3 review(s) available for raloxifene hydrochloride and Coronary Artery Disease
Article | Year |
---|---|
Gender, hyperlipidemia, and coronary artery disease.
Topics: Adult; Aged; Cardiotonic Agents; Coronary Artery Disease; Estrogen Replacement Therapy; Female; Health Behavior; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Life Style; Male; Middle Aged; Primary Prevention; Raloxifene Hydrochloride; Risk Factors; Selective Estrogen Receptor Modulators; Sex Factors | 2003 |
Estrogen replacement therapy, atherosclerosis, and vascular function.
Topics: Aged; Aging; Animals; Coronary Artery Disease; Endothelium, Vascular; Estrogen Replacement Therapy; Estrogens, Non-Steroidal; Female; Humans; Inflammation; Isoflavones; Lipids; Macaca; Male; Middle Aged; Models, Animal; Phytoestrogens; Plant Preparations; Progestins; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators | 2002 |
Controversial issues in climacteric medicine I. Cardiovascular disease and hormone replacement therapy. International Menopause Society Expert Workshop. 13-16 October 2000, royal society of medicine, London, UK.
Topics: Coronary Artery Disease; Female; Hormone Replacement Therapy; Humans; Postmenopause; Raloxifene Hydrochloride | 2000 |
3 trial(s) available for raloxifene hydrochloride and Coronary Artery Disease
Article | Year |
---|---|
Effect of raloxifene on stroke and venous thromboembolism according to subgroups in postmenopausal women at increased risk of coronary heart disease.
Topics: Comorbidity; Coronary Artery Disease; Humans; Incidence; Middle Aged; Mortality; Postmenopause; Raloxifene Hydrochloride; Risk Assessment; Risk Factors; Selective Estrogen Receptor Modulators; Smoking; Stroke; Treatment Outcome; Venous Thromboembolism | 2009 |
Effects of raloxifene on endothelium-dependent dilation, lipoproteins, and markers of vascular function in postmenopausal women with coronary artery disease.
Topics: Aged; Biomarkers; Coronary Artery Disease; Coronary Vessels; Cross-Over Studies; Double-Blind Method; Endothelin-1; Endothelium, Vascular; Female; Fibrinogen; Humans; Lipoproteins; Middle Aged; Postmenopause; Prospective Studies; Prostaglandins; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Vasodilation | 2003 |
The effects of raloxifene and simvastatin on plasma lipids and endothelium.
Topics: Aged; Cell Adhesion Molecules; Coronary Artery Disease; Cross-Over Studies; Double-Blind Method; Endothelium, Vascular; Female; Forearm; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Lipids; Middle Aged; Postmenopause; Raloxifene Hydrochloride; Regional Blood Flow; Selective Estrogen Receptor Modulators; Simvastatin; Vascular Resistance | 2003 |
4 other study(ies) available for raloxifene hydrochloride and Coronary Artery Disease
Article | Year |
---|---|
Lessons from RUTH.
Topics: Breast Neoplasms; Coronary Artery Disease; Female; Humans; Postmenopause; Raloxifene Hydrochloride; Risk Factors; Selective Estrogen Receptor Modulators; Spinal Fractures; Thromboembolism | 2006 |
Why is the RUTH trial so important?
Topics: Aged; Aged, 80 and over; Clinical Trials as Topic; Coronary Artery Disease; Estrogen Replacement Therapy; Female; Humans; Menopause; Middle Aged; Osteoporosis, Postmenopausal; Raloxifene Hydrochloride | 2007 |
Lack of effect of raloxifene on coronary artery atherosclerosis of postmenopausal monkeys.
Topics: Animals; Coronary Artery Disease; Coronary Vessels; Diet, Atherogenic; Estradiol; Estrogens; Female; Horses; Lipids; Lipoproteins; Macaca fascicularis; Osmolar Concentration; Ovariectomy; Piperidines; Postmenopause; Raloxifene Hydrochloride | 1998 |
Comment on lack of effect of raloxifene on coronary artery atherosclerosis of postmenopausal monkeys.
Topics: Animals; Coronary Artery Disease; Estrogen Antagonists; Female; Macaca fascicularis; Piperidines; Postmenopause; Raloxifene Hydrochloride | 1998 |